The genetic-testing company beat expectations with its Q2 results.
Reactions to insider selling by two key leaders sent the stock down for a fourth consecutive day.
Stocks that traded heavily or had substantial price changes on Friday: First Solar, Castle Biosciences rise; Levi Strauss falls
The company received some unexpected good news.
Analysts downgraded their price target for the medical diagnostics stock.
Investors were unimpressed by the company's study regarding its IDgenetix test.
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its financial results for the first quarter ended March 31, 2023.
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced the publication of an independent, multi-center study in the Archives...
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has teamed up with IMPACT Melanoma, one of the nation's leading...
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data showing DecisionDx ® -Melanoma can improve risk stratification...